Oncotarget is a traditional journal that is published every week. The journal covers the research made on all the oncology aspects. The journal has free access and is multidisciplinary. The publication is made online, and it can be printed if one made a special demand. Oncotarget aims at making the results of science widely available to the people. The journal also wants to use the insightful reviews they get to increase the impact the research has. It has tried to get rid of the borders the specialties have and to ensure that those special discoveries that are made are shared as fast as possible. The company has links to various biochemical science fields, and they use this to come up with the application of the clinical science to fight the illnesses.
Oncotarget was created in the year 2010. Impact Journals publishes the paper. The publication has two editors-in-chief. They are; Andrei Gudkov, Mikhail Blagosklonny. Andrei is from the Cancer Institute of Roswell Park. Since the issuance begun, it has published more than 350 papers that have topics related to oxygen. William Kaelin, Jr. and Gregg Semenza are also members of the team. They were awarded the Lasker Award because they discovered the pathway of sensing oxygen. Oncotarget also makes publication from the cancer research papers. The paper will also tend to make some articles on immunology, age-related diseases, Pharmacology, Mol Biology and cell, and pathology. This is because of the integrity of the human organism and the fact that tumor development is a complex issue.
Oncotarget helps researchers to contribute to the progress in the field of science. It does this by having leadership that is of prominent scientists. The paper aims at seeing individuals live without diseases. The success of the publication is what encouraged the paper to deal with other sections apart from oncology. The paper has a board that ensures the issues that are published are only the best ones. They play a major role in the success of journal. They are devoted and have had experience of several years.
Oncotarget goes ahead to allow authors from outside to submit any publications that they have on the related topics. The people who have an interest in writing issues on the same subject now have opportunities. However, they also work to ensure that the articles submitted are of high quality. To them, quality is everything. For this reason, all the writers who wish to submit what they write have to pass all their ethical tests to ensure it is of top quality.
To know more visit @: www.linkedin.com/in/mikhail-blagosklonny-91abb531/